[The validation and procedure of inhalation therapy using 2-component aerosols in obstructive bronchopulmonary diseases].
Ivashkin
V T
VT
Iakovlev
V N
VN
Sinopal'nikov
A I
AI
Antokhin
E A
EA
D000280:Administration, Inhalation; D000328:Adult; D000336:Aerosols; D000368:Aged; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004205:Cromolyn Sodium / Q000008:administration & dosage* / Q000009:adverse effects; D004338:Drug Combinations; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005280:Fenoterol / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage* / Q000009:adverse effects; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012119:Respiration / Q000187:drug effects
D000336:Aerosols; D001993:Bronchodilator Agents; D004338:Drug Combinations; C078581:ditec; C030809:fenoterol, ipratropium drug combination; D005280:Fenoterol; D009241:Ipratropium; D004205:Cromolyn Sodium
Obosnovanie i taktika ingaliatsionnoĭ terapii s ispol'zovaniem dvukhkomponentnykh aérozoleĭ pri obstruktivnykh bronkholegochnykh zabolevaniĭ.